• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Telesis Bio, Inc. - Common Stock (NQ: TBIO )

    1.400 -0.150 (-9.68%)
    Streaming Delayed Price Updated: 3:59 PM EDT, Sep 17, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Telesis Bio, Inc. - Common Stock

    < Previous 1 2 3 4 Next >
    Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up
    New Releases Extend the BioXp® Select Product Line, Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Synthetic Biology Workstation 
    From Telesis Bio
    Via GlobeNewswire
    Why Edible Garden Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Gainers Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) shares jumped 69.6% to $15.01 after dropping 24% on Tuesday. 
    Via Benzinga
    Telesis Bio Earnings Perspective: Return On Capital Employed
    Via Benzinga
    A Preview Of Telesis Bio's Earnings
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Why GameStop Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket
    Gainers 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    The biggest pre-market stock movers are making waves on Wednesday with huge gainers and losers worth watching this morning! 
    Via InvestorPlace
    Telesis Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance
    From Telesis Bio
    Via GlobeNewswire
    Earnings Scheduled For March 21, 2023
    Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.20 per share on revenue of $41.75 million. 
    Via Benzinga
    Telesis Bio to Present at Festival of Biologics Conference
    Daniel Gibson, Ph.D., CTO and Co-founder to Present “Building Biology Overnight: Eliminating Synthesis Bottlenecks with Hands-free Automated Synthetic Biology Solutions” 
    From Telesis Bio
    Via GlobeNewswire
    Telesis Bio to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, March 21, 2023
    From Telesis Bio
    Via GlobeNewswire
    Telesis Bio to Present at the Cowen 43rd Annual Healthcare Conference
    From Telesis Bio
    Via GlobeNewswire
    Telesis Bio Releases BioXp® Select mRNA Synthesis Kit to Expand the Utility, Speed, and Impact of Its Automated Synthetic Biology Workstation
    Scientists Can Now Begin the mRNA Synthesis Process from Their Own Sequence or Plasmid DNA 
    From Telesis Bio
    Via GlobeNewswire
    Why Broadwind Shares Are Trading Higher By 85%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Gainers Broadwind Inc (NASDAQ: BWEN) shares climbed 85.4% to $4.19 after the company announced the receipt of approximately $175 million in new tower orders from a leading global wind turbine... 
    Via Benzinga
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.